Cision

November 28, 2024

Antengene Announces XPOVIO®'s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country

PRNewswire

November 28, 2024

Antengene Announces XPOVIO®'s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country

PRNewswire

November 28, 2024

Antengene Announces XPOVIO®'s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country

PRNewswire

November 28, 2024

Antengene Announces XPOVIO®'s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country

PRNewswire

November 28, 2024

ASSEMBLY ELEVATES VIVIAN MOK TO SVP & MANAGING DIRECTOR FOR NORTH ASIA

PRNewswire

November 28, 2024

ASSEMBLY ELEVATES VIVIAN MOK TO SVP & MANAGING DIRECTOR FOR NORTH ASIA

PRNewswire

November 28, 2024

Team T5 Applauded by Frost & Sullivan for Deeply and Effectively Monitoring Regional Adversaries and Incidents

PRNewswire

November 28, 2024

Team T5 Applauded by Frost & Sullivan for Deeply and Effectively Monitoring Regional Adversaries and Incidents

PRNewswire

November 28, 2024

Team T5 Applauded by Frost & Sullivan for Deeply and Effectively Monitoring Regional Adversaries and Incidents

PRNewswire

November 28, 2024

Hangzhou Hosts Second Liangzhu Forum with Global Cultural Leaders

PRNewswire

November 28, 2024

Hangzhou Hosts Second Liangzhu Forum with Global Cultural Leaders

PRNewswire

November 28, 2024

Hangzhou Hosts Second Liangzhu Forum with Global Cultural Leaders

PRNewswire

November 28, 2024

Hangzhou Hosts Second Liangzhu Forum with Global Cultural Leaders

PRNewswire

November 28, 2024

XREX CISO Leads DeFiHackLabs To Victory at SCAN 2024, the World's First Digital Asset Tracking Challenge

PRNewswire